Last Updated January 21, 2024

 January 21, 2024

Researchers looking to investigate the realm of peptides for libido, erectile dysfunction, and sexual health — might be curious about the most effective compounds for this condition.

Several researchers peptides have indeed been associated with advantages such as:

  • Improved erectile function
  • Enhanced orgasms
  • Higher sexual satisfaction
  • Increased testosterone levels
  • Improved hormonal balance

To help researchers out, we have gathered recent clinical data to compile this comprehensive guide on therapeutic peptides for male libido, erectile dysfunction, and sexual health.

In this thorough review, researchers will learn about the most potent peptides for erectile function and sexual performance, including their mechanisms of action, efficacy, safety profiles, and potential side effects.

Buy research peptides from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.


Top 3 Peptides For Libido, Erectile Dysfunction, and Sexual Health

Without further ado, let’s preview three of the most potent peptides for erectile function and sexual performance in men.

1. PT-141

PT-141 (bremelanotide) is a synthetic agonist of the melanocortin receptors in the brain that influence sex drive, appetite, and metabolism. The peptide is approved for hypoactive sexual desire disorder (HSDD) in premenopausal women under the band name Vyleesi, but has not been formally authorized for use in men [1].

Nonetheless, research reveals that PT-141 can significantly boost libido and sexual desire in men while substantially increasing the duration of erections. PT-141 may also be an alternative for men who don’t respond to PDE5 inhibitors like Viagra (sildenafil) [2, 3].

2. Melanotan II

Melanotan II is another synthetic melanocortin receptor agonist that interacts with the melanocortin system. In fact, PT-141 is one of its active metabolites. While melanotan II is typically used to achieve a sunless tan, research suggests that it may also improve sexual desire and erectile function in males with erectile dysfunction (ED), regardless of whether their ED is psychogenic or organic [4].

3. Oxytocin

Oxytocin is a naturally-occurring hormone that is commonly administered to women in medical practice. Research also shows that when administered to men, the peptide may help improve orgasm intensity, sexual contentment, and overall sexual satisfaction. Preliminary research also reports cases of improved libido and erections [5, 6].


Peptides for libido


What is Peptide Therapy?

Peptide therapy is defined as the therapeutic use of peptide-based compounds. Peptides are molecules made of amino acids linked into amino acid chains, similar to proteins.

Many peptides occur naturally in the human body, where they exert a variety of functions. By definition, peptides are shorter than proteins and consist of 2-50 amino acids. They usually have a linear structure, but some peptides, such as PT-141, may also be cyclical or nonlinear [7].

Peptide therapeutics can manage a range of psychological processes like brain functions, growth, metabolism, recovery, intercellular communication, and endocrine signaling. With their vast potential, these molecules have attracted significant attention for the management of a wide range of conditions [7, 8].

At present, more than 60 peptide-based medications have received regulatory approval in the United States, and countless others are currently under investigation for their therapeutic potential [8, 9].


How Do Peptides Work For Erectile Dysfunction and Libido?

Peptides have emerged as a promising area of research for the improvement of erectile dysfunction (ED) and overall sexual health in men. They appear to work via a variety of mechanisms to exert beneficial effects for male sexual health, including enhanced erectile function, increased libido, and improved hormonal balance.

Two of the most notable peptides for ED are PT-141 and melanotan II, both of which work by activating several melanocortin receptors in the body. Both are known to activate the melanocortin receptors 3 and 4 in the brain, which are associated with increased sexual desire. Activating them may also upregulate the production of vasodilators (nitric oxide) in the penis, leading to erection [2, 3, 10].

Oxytocin is also reported to work by activating the corresponding oxytocin receptors, potentially resulting in increased orgasm intensity, sexual satisfaction, and erectile function [11].

Some peptides may also improve hormonal balance and increase testosterone levels in men, thus supporting normal sexual function and erections. Here are example scenarios [12, 13, 14]:

  • High amounts of body fat can lead to cardiovascular problems and increased aromatization of testosterone (T) into estrogen, ultimately lowering T synthesis. Weight loss peptides such as tirzepatide can help shed excess fat and reduce aromatization.
  • Some endocrine issues can affect hypothalamic-pituitary-gonadal (HPG) axis function, leading to low T and ED. Peptides such as kisspeptin-10 may directly stimulate the function of the HPG-axis and increase testosterone levels, thereby improving erections.

Do Peptides For Sexual Health *Actually* Work?

Substantial clinical evidence confirms that peptides for sexual health are effective in improving erectile function and male libido. For example, one phase-2A study with PT-141, which included 73 men (both healthy and with ED), revealed that the peptide could cause a significant increase in the duration of erections [15].

The mean duration of base rigidity at or above 80% was notably longer for men with erectile dysfunction (ED) receiving PT-141 compared to those receiving placebo. Specifically, patients receiving PT-141 at 4-6mg doses exhibited a mean duration of base rigidity of 14-17 minutes.

By contrast, patients who were administered placebo showed a mean duration of base rigidity of only 2 minutes. Further, a more than two-fold increase in the duration of base rigidity at or above 60% was observed when comparing the response of individual patients to PT-141 versus placebo [15].

Another melanocortin agonist, melanotan II (MT-2), has also been reported as helpful in improving ED in men with either psychological or organic ED. In one study, MT-2 has been reported to cause an improvement in 85% of subjects with ED, both psychological and organic [4].


Peptides for libido


Best Peptides For ED, Libido, and Sexual Health

There are numerous peptides for erectile dysfunction that work in various ways, including for improving libido, testosterone levels, hormonal balance, and more.

Keep reading to discover the most actively researched peptides, including a detailed explanation of their distinctive features, mechanisms, and clinical data.

Peptides For Libido and ED

The most well-studied peptides for erectile function and male libido are the analogs of the naturally-occurring α-melanocyte stimulating hormone (alpha-MSH), which stimulate the melanocortin receptors 3 (MC3-R) and 4 (MC4-R) in the brain [16]. The two most notable examples are:

Also known as bremelanotide, this peptide is an active metabolite of the melanocortin agonist melanotan II. Despite the fact that PT-141 is FDA-approved for use in premenopausal women, the peptide is also well-studied in male subjects struggling with sexual health disorder [1].

PT-141 has shown great effectiveness in improving erectile function in both healthy men, and men with ED, applied either intranasally or subcutaneously [15,17].

In one small study with 24 healthy men, intranasal doses of PT-141 ranging from 4 to 20mg led to a substantial increase in the duration of rigid erections. On average, these erections lasted 140 minutes (more than 6-fold longer), compared to just 22 minutes in the placebo group [2].

The peptide was also effective at improving erections in males suffering from ED who did not respond to the phosphodiesterase-5 (PDE5) inhibitor sildenafil (Viagra).

Positive clinical results were seen in 33.5% of subjects in the PT-141 group compared with 8.5% of the placebo group. Ultimately, the researchers posited that PT-141 may be a candidate for therapy in men who don't respond to PDE5 inhibitors [3].

Buy PT-141 from our top-rated vendor...


This research peptide was initially studied as a tanning agent due to its affinity to melanocortin receptor 1 (MC1-R). However, research has shown that it is also a potent libido-boosting and erectogenic agent. The peptide has been studied in both men and women for its effects on sexual function and libido [18, 19].

Research on melanotan II in males with ED indicates that when administered as a subcutaneous injection, MT-2 can significantly improve erectile function. One study saw an improvement in the ED of 85% of subjects, regardless of whether the ED was caused by psychological or organic factors [4].

The authors reported a mean of 41min of rigidity and increased sexual desire in about 68% of the participants. Considering the beneficial effects of melanotan II on both libido and erections, the authors suggested it may also be a candidate therapy in ED unresponsive to PDE5 inhibitors [4].

Buy Melanotan 2 from our top-rated vendor...


Peptides For Hormone Levels

Testosterone is essential for normal erectile function and libido in males. Processes controlling penile erections, such as nitric oxide (NO) production (and degradation) as well as adenosine signaling, are all androgen-dependent [20].

Therefore, ensuring optimal T levels is paramount for improving erectile function, managing ED, and increasing sex drive. Here are the best peptides for sexual health when testosterone levels may be of concern:

Also known as metastin (45-54) or KP 45–54, this peptide originates from the peptide kisspeptin-54, itself derived from the KISS1 gene [21]. The gene is found in hypothalamic cells and produces a polypeptide that forms various kisspeptin sequences, which are key to regulating reproductive hormones [22, 23].

Kisspeptin-10 signals GnRH-releasing neurons in the hypothalamus to regulate the pulsatile release of gonadotropin-releasing hormone (GnRH), leading to increased production of gonadotropins, namely luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

These hormones are produced by the pituitary and stimulate the production of testosterone in the testes. In fact, increased levels of LH and FSH are associated with improved fertility and elevated testosterone levels in male subjects [23, 24].

In fact, clinical research indicates kisspeptin-10 enhances the effects of reproductive hormones and increases LH pulsatile secretion, while continuous administration may also boost testosterone levels [12].

Buy Kisspeptin-10 from our top-rated vendor...


This peptide is bioidentical to endogenous gonadotropin hormone-releasing hormone, and used for diagnostic purposes to evaluate the functional integrity of the hypothalamic–pituitary–gonadal (HPG) axis. Additionally, it is used therapeutically to induce ovulation in women with irregular ovulation and menstrual cycles due to GnRH insufficiency [25].

Research shows that gonadorelin can effectively stimulate HPG function in males with hypothalamic dysfunction and GnRH insufficiency [26]. It can also increase testosterone levels and fertility, provided that the testes and the pituitary gland are functional [27, 28].

Buy Gonadorelin from our top-rated vendor...


This tetrapeptide, also known as KEDG (Lys-Glu-Asp-Gly), is among numerous short signaling peptides discovered and studied by Professor Vladimir Khavinson, a Russian gerontologist and academician [29].

Testagen has been studied for its potential effects on testosterone synthesis, more specifically as a treatment for androgen deficiency in patients with chronic abacterial prostatitis.

For example, a study found that treatment with Testagen resulted in improved uroflowmetric parameters, decreased inflammation in the prostate, and increased total testosterone levels in the test subjects [30].


Peptides For Sexual Satisfaction

Orgasm intensity and sexual satisfaction are also key aspects of men's sexual health.

Here is one peptide that may improve orgasms and emotional state after sexual intercourse:

This is a naturally-occurring peptide hormone and neurotransmitter produced in the hypothalamus and released by the pituitary gland. It plays a crucial role in childbirth and lactation, prompting uterine contractions during labor and milk release during breastfeeding, hence its medical use in inducing and augmenting labor and managing postpartum bleeding [31].

Beyond these functions, oxytocin has been studied for its effects on social bonding, stress reduction, and, notably, male sexual function. Research indicates that oxytocin can enhance the intensity of male orgasm, increase sexual contentment, and heighten feelings of sexual satiety in men following intercourse [5].

A case study even reported significant improvements in libido, erection, and orgasm in a male patient following intranasal oxytocin administration [6].


Peptides For Weight Loss And Cardiovascular Health

Being overweight or obese can have a negative effect on male sexual health for several reasons, including an increased risk of hormonal imbalance and atherosclerosis.

Adipose tissue is a site of aromatization in which androgens such as testosterone are converted to estrogens. In turn, the increased estrogen levels suppress the HPG axis and lower testosterone levels, which may cause erectile dysfunction, a chronic disorder [13].

Excess fat can also increase the risk of atherosclerosis and pave the way to other cardiovascular problems that are commonly associated with ED [32].

Peptides that can help address weight loss and cardiovascular risk factors in research settings include:

This novel dual-incretin agonist mimics the function of the incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This gives tirzepatide its glucose-lowering and appetite-suppressing effects.

Tirzepatide is already approved as a glucose-lowering medication in patients with type 2 diabetes (T2D) and is currently being investigated in phase-3 trials for its weight loss benefits. One of the available phase-3 trials, which included 2539 subjects, reported impressive results, boasting over 20% weight loss within 72 weeks [14].

Such substantial weight loss and body fat reduction may provide significant improvement in hormonal balance and testosterone levels in men.

In addition, there is also an ongoing trial investigating whether tirzepatide can improve long-term cardiovascular outcomes in diabetic patients who are at an increased risk of heart disease. Improving cardiovascular health can also help with certain forms of ED [33].

Buy Tirzepatide from our #1 recommended vendor...


This GLP-1 agonist is already approved for weight loss in non-diabetics, as well as for reducing cardiovascular risk and improving glycemic control in T2D [34, 35]. Studies in nondiabetics report that the peptide can lead to as much as 17% weight loss after 68 weeks of therapy [35].

Apart from potentially improving ED symptoms and testosterone levels via inducing weight loss, semaglutide may also help reduce inflammation and atherosclerosis progression [36, 37]. Improving cardiovascular health can in turn provide significant benefits for sexual health and erectile function.

Semaglutide is also under investigation as a medication for cardiovascular risk reduction in non-diabetics in an ongoing clinical program called SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) [38].

Buy Semaglutide from our top-rated vendor...


Peptides For ED | Side Effects and Safety

Peptides for erectile dysfunction and libido can have a variety of side effects that will depend on the specific compound.

Overall, the peptides mentioned above have favorable safety profiles based on clinical research. Here is a breakdown of safety data for the peptides on our list:

  • PT-141

In a large trial in men with ED, the most common side effects in the PT-141 group (172 men) were [3]:

  • Nausea – 22 participants (12.8%)
  • Flushing – 18 (10.5%)
  • Diaphoresis – 16 (9.3%)
  • Low back pain – 12 (7%)
  • Taste disturbances – 8 (4.7%)

The nausea was reported as moderate, while other side effects were reported as mild. The peptide was taken for at least 16 doses but no more than one dose per day. There were no serious adverse reactions [3].

  • Melanotan II

A published clinical trial in men reported that after two applications, the peptide caused nausea, yawning or stretching, facial flushing, appetite changes, and drowsiness. Nausea and stretching/yawning were the most frequently reported side effects, and they ranged from mild to severe. The trial did not report serious side effects [4].

A case study involving longer use suggested that prolonged application of melanotan II (up to 4 weeks) may increase the risk of melanoma. However, it is important to note that the case study in question reports a woman who used the peptide as a part of an intensive sunbed tanning procedure, and sunbeds are known to significantly elevate melanoma risk [39].

  • Kisspeptin-10 & Gonadorelin

Studies with kisspeptin and gonadorelin do not report any adverse events, except for an increased risk of allergic reactions in one gonadorelin study [12, 26]. In addition, gonadorelin may lead to undesired effects related to increased testosterone levels, such as facial acne and breast tenderness, especially when used to induce puberty in male subjects [26].

  • Oxytocin

Side effects of oxytocin are generally mild and rare. They may include nausea, headache, and blood pressure changes [31].

  • Tirzepatide & Semaglutide

Tirzepatide and semaglutide often cause gastrointestinal side effects, which are typical for incretin mimetics. These usually occur in 40-70% of test subjects, and the most frequent ones are nausea and diarrhea. Infrequently (less than 2% of cases), use of either compound can lead to mild to moderate hepatobiliary disorders like gallstones and pancreatitis [40].


Peptides for libido


Peptides For Libido, Erectile Dysfunction, and Sexual Health | FAQ

Below, we provide evidence-based answers to the most commonly asked questions by researchers in the field of peptides for erectile dysfunction, libido, and male sexual wellness.

Which peptide is best for erectile dysfunction?

Overall, PT-141 appears to be the peptide that is best researched and best suited for erectile dysfunction management. However, other peptides such as kisspeptin-10 or tirzepatide may also prove beneficial, depending on the underlying cause(s) of ED.

How does PT-141 work in male researchers?

PT-141 works by activating the melanocortin receptors in the brain, with a preference for the melanocortin-3 and melanocortin-4 receptors, which are known for their role in appetite, metabolism, and, most importantly, sexual function. By activating these receptors, PT-141 can significantly increase libido in men and induce prolonged erections [15, 17].

What is the benefit of PT-141 peptide?

The main benefit of PT-141 for males with ED is increased sexual desire and prolonged erections [2].


Peptides and Libido | Verdict

Peptides such as PT-141, melanotan II, oxytocin, and kisspeptin-10 have been shown to improve among the most common sexual problems in men, including erectile dysfunction, low libido, lack of sexual satisfaction, and hormonal imbalances.

The available scientific research also suggests that these peptides have excellent safety profiles, and several compounds, including PT-141, are already approved for clinical use, albeit not for males.

When conducting research on the implications of peptides on male sexual wellbeing, it's crucial to obtain reference materials from a reliable source.

This research peptides company stands out as our top recommendation for obtaining high-quality peptides for research or experimental use.


References

  1. Edinoff, A. N., Sanders, N. M., Lewis, K. B., Apgar, T. L., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022). Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurology international, 14(1), 75–88. https://doi.org/10.3390/neurolint14010006
  2. Molinoff, P. B., Shadiack, A. M., Earle, D., Diamond, L. E., & Quon, C. Y. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences, 994, 96–102. https://doi.org/10.1111/j.1749-6632.2003.tb03167.x
  3. Safarinejad, M. R., & Hosseini, S. Y. (2008). Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. The Journal of urology, 179(3), 1066–1071. https://doi.org/10.1016/j.juro.2007.10.063
  4. Wessells, H., Levine, N., Hadley, M. E., Dorr, R., & Hruby, V. (2000). Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International journal of impotence research, 12 Suppl 4, S74–S79. https://doi.org/10.1038/sj.ijir.3900582
  5. Behnia, B., Heinrichs, M., Bergmann, W., Jung, S., Germann, J., Schedlowski, M., Hartmann, U., & Kruger, T. H. (2014). Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Hormones and behavior, 65(3), 308–318. https://doi.org/10.1016/j.yhbeh.2014.01.009
  6. MacDonald, K., & Feifel, D. (2012). Dramatic improvement in sexual function induced by intranasal oxytocin. The journal of sexual medicine, 9(5), 1407–1410. https://doi.org/10.1111/j.1743-6109.2012.02703.x
  7. Forbes, J., & Krishnamurthy, K. (2022). Biochemistry, Peptide. In StatPearls. StatPearls Publishing.
  8. Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal transduction and targeted therapy, 7(1), 48. https://doi.org/10.1038/s41392-022-00904-4
  9. Lee, A. C., Harris, J. L., Khanna, K. K., & Hong, J. H. (2019). A Comprehensive Review on Current Advances in Peptide Drug Development and Design. International journal of molecular sciences, 20(10), 2383. https://doi.org/10.3390/ijms20102383
  10. Wessells, H., Blevins, J. E., & Vanderah, T. W. (2005). Melanocortinergic control of penile erection. Peptides, 26(10), 1972–1977. https://doi.org/10.1016/j.peptides.2004.11.035
  11. Melis, M. R., & Argiolas, A. (2021). Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances. International journal of molecular sciences, 22(19), 10376. https://doi.org/10.3390/ijms221910376
  12. George, J. T., Veldhuis, J. D., Roseweir, A. K., Newton, C. L., Faccenda, E., Millar, R. P., & Anderson, R. A. (2011). Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. The Journal of clinical endocrinology and metabolism, 96(8), E1228–E1236. https://doi.org/10.1210/jc.2011-0089
  13. Sarwer, D. B., Hanson, A. J., Voeller, J., & Steffen, K. (2018). Obesity and Sexual Functioning. Current obesity reports, 7(4), 301–307. https://doi.org/10.1007/s13679-018-0319-6
  14. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England journal of medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  15. Rosen, R. C., Diamond, L. E., Earle, D. C., Shadiack, A. M., & Molinoff, P. B. (2004). Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. International journal of impotence research, 16(2), 135–142. https://doi.org/10.1038/sj.ijir.3901200
  16. Wikberg, J. E., & Mutulis, F. (2008). Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction. Nature reviews. Drug discovery, 7(4), 307–323. https://doi.org/10.1038/nrd2331
  17. Diamond, L. E., Earle, D. C., Rosen, R. C., Willett, M. S., & Molinoff, P. B. (2004). Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. International journal of impotence research, 16(1), 51–59. https://doi.org/10.1038/sj.ijir.3901139
  18. Hadley M. E. (2005). Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides, 26(10), 1687–1689. https://doi.org/10.1016/j.peptides.2005.01.023
  19. Ückert, S., Bannowsky, A., Albrecht, K., & Kuczyk, M. A. (2014). Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies. Expert opinion on investigational drugs, 23(11), 1477–1483. https://doi.org/10.1517/13543784.2014.934805
  20. Corona, G., & Maggi, M. (2022). The role of testosterone in male sexual function. Reviews in endocrine & metabolic disorders, 23(6), 1159–1172. https://doi.org/10.1007/s11154-022-09748-3
  21. Kotani, M., Detheux, M., Vandenbogaerde, A., Communi, D., Vanderwinden, J. M., Le Poul, E., Brézillon, S., Tyldesley, R., Suarez-Huerta, N., Vandeput, F., Blanpain, C., Schiffmann, S. N., Vassart, G., & Parmentier, M. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. The Journal of biological chemistry, 276(37), 34631–34636. https://doi.org/10.1074/jbc.M104847200
  22. Comninos, A. N., Yang, L., O'Callaghan, J., Mills, E. G., Wall, M. B., Demetriou, L., Wing, V. C., Thurston, L., Owen, B. M., Abbara, A., Rabiner, E. A., & Dhillo, W. S. (2021). Kisspeptin modulates gamma-aminobutyric acid levels in the human brain. Psychoneuroendocrinology, 129, 105244. https://doi.org/10.1016/j.psyneuen.2021.105244
  23. Curtis, A. E., Cooke, J. H., Baxter, J. E., Parkinson, J. R., Bataveljic, A., Ghatei, M. A., Bloom, S. R., & Murphy, K. G. (2010). A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. American journal of physiology. Endocrinology and metabolism, 298(2), E296–E303. https://doi.org/10.1152/ajpendo.00426.2009
  24. Thompson, E. L., Patterson, M., Murphy, K. G., Smith, K. L., Dhillo, W. S., Todd, J. F., Ghatei, M. A., & Bloom, S. R. (2004). Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. Journal of neuroendocrinology, 16(10), 850–858. https://doi.org/10.1111/j.1365-2826.2004.01240.x
  25. Weiss, N. S., Kostova, E., Nahuis, M., Mol, B. W. J., van der Veen, F., & van Wely, M. (2019). Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. The Cochrane database of systematic reviews, 1(1), CD010290. https://doi.org/10.1002/14651858.CD010290.pub3
  26. Zhang, L., Cai, K., Wang, Y., Ji, W., Cheng, Z., Chen, G., & Liao, Z. (2019). The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men. American journal of men's health, 13(1), 1557988318818280. https://doi.org/10.1177/1557988318818280
  27. Blumenfeld, Z., Makler, A., Frisch, L., & Brandes, J. M. (1988). Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2(2), 151–164. https://doi.org/10.3109/09513598809023623
  28. Happ, J., Ditscheid, W., & Krause, U. (1985). Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty. Fertility and sterility, 43(4), 599–608. https://doi.org/10.1016/s0015-0282(16)48504-3
  29. Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. R. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (Basel, Switzerland), 26(22), 7053. https://doi.org/10.3390/molecules26227053
  30. Rossikhin, V. V., Hoshchenko, Y. O., & Osipov, P. G. (2011). EFFICACY OF TESTOSTERONE SYNTHESIS INDUCTOR APPLICATION” TESTAGEN” IN ANDROGENIC DEFICIENCY IN PATIENTS WITH CHRONIC ABACTERIAL PROSTATITIS. Problems of Endocrine Pathology, 36(2), 17-22.
  31. Zeng, Y., Zhang, Y., Zhen, M., Lao, L., Ma, Y., Liu, L., Fan, D., & Ai, W. (2022). Side-effects of oxytocin in postpartum hemorrhage: a systematic review and meta-analysis. American journal of translational research, 14(3), 1934–1951.
  32. Ibrahim, A., Ali, M., Kiernan, T. J., & Stack, A. G. (2018). Erectile Dysfunction and Ischaemic Heart Disease. European cardiology, 13(2), 98–103. https://doi.org/10.15420/ecr.2017.21.3
  33. National Library of Medicine (U.S.). (2020, May 29 – ). A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT). Identifier NCT04255433. https://www.clinicaltrials.gov/ct2/show/NCT04255433
  34. Aroda, V. R., Blonde, L., & Pratley, R. E. (2022). A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Reviews in endocrine & metabolic disorders, 23(5), 979–994. https://doi.org/10.1007/s11154-022-09735-8
  35. Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022). Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations. Drug design, development and therapy, 16, 4449–4461. https://doi.org/10.2147/DDDT.S365416
  36. Mosenzon, O., Capehorn, M. S., De Remigis, A., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022). Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials. Cardiovascular diabetology, 21(1), 172. https://doi.org/10.1186/s12933-022-01585-7
  37. Rakipovski, G., Rolin, B., Nøhr, J., Klewe, I., Frederiksen, K. S., Augustin, R., Hecksher-Sørensen, J., Ingvorsen, C., Polex-Wolf, J., & Knudsen, L. B. (2018). The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways. JACC. Basic to translational science, 3(6), 844–857. https://doi.org/10.1016/j.jacbts.2018.09.004
  38. Lingvay, I., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lincoff, A. M., Marso, S. P., Fries, T. M., Plutzky, J., Ryan, D. H., & SELECT Study Group (2023). Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics. Obesity (Silver Spring, Md.), 31(1), 111–122. https://doi.org/10.1002/oby.23621
  39. Hjuler, K. F., & Lorentzen, H. F. (2014). Melanoma associated with the use of melanotan-II. Dermatology (Basel, Switzerland), 228(1), 34–36. https://doi.org/10.1159/000356389
  40. Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., de Torres-Sánchez, A., García-de-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., Górriz, J. L., & Rubio-Herrera, M. Á. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of clinical medicine, 12(1), 145. https://doi.org/10.3390/jcm12010145

Scientifically Fact Checked by:

David Warmflash, M.D.

Table of Contents
    Add a header to begin generating the table of contents